Stocks · Health care · Pharmaceutical Preparations

TG THERAPEUTICS, INC.

TGTX Clue Score73
United States Fiscal year ends December CIK 0001001316 Results filed 3 Aug 2026

What the insiders did No buying or selling

By person

7 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Michael S Weiss
CEO
—
—
—
9,778,086
$537.40M
−25.2%
Sean A Power
CFO
—
—
—
798,111
$43.86M
+24.3%
Kenneth Hoberman
Director
—
—
—
279,653
$15.37M
+5.6%
Yann Echelard
Director
—
—
—
223,816
$12.30M
−0.1%
Daniel Hume
Director
—
—
—
192,748
$10.59M
−19.9%
Laurence N Charney
Director
—
—
—
168,640
$9.27M
−29.0%
Sagar Lonial
Director
—
—
—
94,061
$5.17M
−10.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.